| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |